Array BioPharma’s new colorectal cancer treatment gains breakthrough therapy designation from FDA

Array BioPharma has achieved a significant regulatory milestone as its innovative combination therapy for metastatic colorectal cancer (mCRC) has been granted breakthrough therapy designation by ... Read More